10X Genomics, Inc. (TXG)
68.59
+2.21
(+3.33%)
USD |
NASDAQ |
Sep 11, 16:00
68.03
-0.56
(-0.82%)
After-Hours: 05:14
10X Genomics Market Cap : 8.936B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 8.936B |
| September 10, 2026 | 8.648B |
| September 09, 2026 | 8.767B |
| September 08, 2026 | 8.547B |
| September 04, 2026 | 8.162B |
| September 03, 2026 | 8.236B |
| September 02, 2026 | 8.032B |
| September 01, 2026 | 7.814B |
| August 31, 2026 | 8.136B |
| August 28, 2026 | 8.018B |
| August 27, 2026 | 8.449B |
| August 26, 2026 | 8.372B |
| August 25, 2026 | 8.432B |
| August 24, 2026 | 8.312B |
| August 21, 2026 | 8.484B |
| August 20, 2026 | 8.321B |
| August 19, 2026 | 8.102B |
| August 18, 2026 | 7.248B |
| August 17, 2026 | 7.555B |
| August 14, 2026 | 7.308B |
| August 13, 2026 | 7.576B |
| August 12, 2026 | 7.524B |
| August 11, 2026 | 7.619B |
| August 10, 2026 | 7.631B |
| August 07, 2026 | 6.779B |
| Date | Value |
|---|---|
| August 06, 2026 | 5.941B |
| August 05, 2026 | 6.183B |
| August 04, 2026 | 6.235B |
| August 03, 2026 | 6.064B |
| July 31, 2026 | 6.097B |
| July 30, 2026 | 6.376B |
| July 29, 2026 | 5.975B |
| July 28, 2026 | 6.069B |
| July 27, 2026 | 5.923B |
| July 24, 2026 | 5.968B |
| July 23, 2026 | 6.199B |
| July 22, 2026 | 6.069B |
| July 21, 2026 | 6.088B |
| July 20, 2026 | 5.575B |
| July 17, 2026 | 5.642B |
| July 16, 2026 | 5.737B |
| July 15, 2026 | 5.901B |
| July 14, 2026 | 5.906B |
| July 13, 2026 | 5.388B |
| July 10, 2026 | 5.512B |
| July 09, 2026 | 5.559B |
| July 08, 2026 | 4.833B |
| July 07, 2026 | 4.880B |
| July 06, 2026 | 5.160B |
| July 02, 2026 | 5.032B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Twist Bioscience Corp. | 7.973B |
| Personalis, Inc. | 1.724B |
| Alamar Biosciences, Inc. (California) | 1.935B |
| Tempus AI, Inc. | 10.63B |
| Adaptive Biotechnologies Corp. | 3.849B |
Market Cap Related Metrics
| PS Ratio | 14.20 |
| Price to Book Value | 10.82 |
| Price to Free Cash Flow | 72.14 |
| Price | 68.59 |
| Earnings Yield | -0.86% |